• Aucun résultat trouvé

inflammatory diseases

23rd Nantes Actualités Transplantation: "Genomics and Immunogenetics of Kidney and Inflammatory Diseases-Lessons for Transplantation"

23rd Nantes Actualités Transplantation: "Genomics and Immunogenetics of Kidney and Inflammatory Diseases-Lessons for Transplantation"

... The 23rd annual “Nantes Actualités Transplantation” meeting took place in Nantes, France (May 31 to June 1, 2018; http://www.nat.nantes.inserm.fr/index.php/en/). This meeting focused on several “omic” approaches, ...

6

Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review

Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review

... and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review Eric Grignano 1* , Arsene Mekinian 1* , Thorsten Braun 2 , Eric Liozon 3 , Mohamed ...

14

Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?

Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?

... chronic inflammatory diseases (AICID) includ- ing rheumatoid arthritis (RA), multiple sclerosis (MS), systemic lupus erythematosus (SLE), or systemic sclerosis (SSc) constitute an important medical, social, ...

6

Myocarditis in auto-immune or auto-inflammatory diseases

Myocarditis in auto-immune or auto-inflammatory diseases

... auto-inflammatory diseases, as it may potentially guide therapy aimed at reducing adverse cardiovascular ...auto-inflammatory diseases have potential benefit but further studies are ...

20

Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases

Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases

... several inflammatory diseases such as obesity, atherosclerosis, cancer, viral and parasite infections, and auto-inflammatory syndromes as well as liver ...liver diseases, of which the etiology ...

20

Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies

Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies

... CD4 + T cells occupy central stage in the process of immune response by coordinating with different immune cells. Being effector cells, they are critical in generation, sustenance and regulation of immune response ...

34

Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases.

Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases.

... Chronic inflammatory diseases are often associated with uncontrolled IFN-α production by PDC. Such IFN- α secretion is notably found in systemic lupus erythe- matosus, 42,43 psoriasis 23,32 and in ...

12

Cancer risk in immune-mediated inflammatory diseases (IMID).

Cancer risk in immune-mediated inflammatory diseases (IMID).

... infections, inflammatory and autoimmune diseases, and cancer, can inhibit tumor immunosurveillance and suppress natural killer cells ...of inflammatory signals [27], integrating sig- nals from a ...

12

Vaccinations in patients with immune-mediated inflammatory diseases.

Vaccinations in patients with immune-mediated inflammatory diseases.

... immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immunomodulatory ...

15

Autoimmune and inflammatory diseases following COVID-19

Autoimmune and inflammatory diseases following COVID-19

... multisystem inflammatory syndrome in children (MIS-C), as it is also known) has left clinicians and the scientific community with several questions about how and why it follows SARS-CoV-2 infection in certain ...

6

Inflammation and Inflammatory Diseases: How Our Language Influences Our Therapeutic Paradigms

Inflammation and Inflammatory Diseases: How Our Language Influences Our Therapeutic Paradigms

... the diseases, it remains the same: the tissues are ...degenerative diseases, the pathologic connection is no longer between acute or chronic inflammation and disease, but between incomplete or failed ...

5

Vasculature targeting for the treatment of cancer and inflammatory diseases : looking for ligands of E selection and endoglin

Vasculature targeting for the treatment of cancer and inflammatory diseases : looking for ligands of E selection and endoglin

... L’ADN de clones issus du 2 ème et 3 ème passage a été séquencé pour chaque expérience ( cf. Par contre, à chaque fois, des phages ne possédant pas d’insert ont été sélectionnés. Ces p[r] ...

138

NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases

NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases

... Inflammasome in cardiovascular diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302 ...

13

Phenotyping of Adaptive Immune Responses in Inflammatory Diseases

Phenotyping of Adaptive Immune Responses in Inflammatory Diseases

... ones, resembles searching for a needle in a haystack. (ii) The second is about sampling: where, and how much? Indeed, how much of the immune response targeting a pulmonary infection is represented in 10 5 cells from ...

9

Gut microbiome in Chronic Rheumatic and Inflammatory Bowel Diseases: similarities and differences

Gut microbiome in Chronic Rheumatic and Inflammatory Bowel Diseases: similarities and differences

... Concerning RA patients, a fewer Firmicutes of the Ruminococcaceae family but an increase in Lactobacillus species and Faklamia have been observed 62,67 . A study by Picchianti- Diamanti et al. characterized the gut ...

40

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

... The European legislation has offered since 2006 a legal framework for biosimilars. The concept and methodology of the comparative investigations are further treated in the guidelines of the European Medicines Agency ...

7

The Dual Role of Neutrophils in Inflammatory Bowel Diseases

The Dual Role of Neutrophils in Inflammatory Bowel Diseases

... regulatory mechanisms of elastase activity, and its interactions with endogenous inhibitors in disease conditions [ 123 ]. 4.4. Other Pro-Inflammatory Mediators Released by Neutrophils Besides MMPs, neutrophils ...

24

Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases

Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases

... respiratory diseases are not considered major multimorbidities, although some studies have found an increased prevalence of chronic obstructive pulmonary disease (COPD) or obstructive sleep apnea syndrome (OSAS) ...

7

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.

... Addressing and improving the cumulative burden of disease, returning to a "normal life," and preventing disability are now major therapeutic goals in IBD. 10 Because of this, it is increasingly important to ...

10

Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients

Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients

... During the follow-up, at least one switch was needed for 13/15 patients under TNF-α antagonists (Figure 1A), 13/16 patients under anakinra (Figure 1B), 8/12 patients with rituximab (Figure 1C) and 9/10 patients under ...

23

Show all 979 documents...

Sujets connexes